Exploring the Diagnostic Utility of 68Ga-FAPI-46 PET/CT in Diverse Pulmonary Pathologies
68 Ga-FAPI-46 PET/CT exhibits potential as an alternative to FDG PET for lung lesion characterization, but requires cautious interpretation due to possible false-positive findings from benign lesions and false-negative findings from low-grade tumors, necessitating histopathologic confirmation.
Authors
- Gaurav Prakash (ORCID: https://orcid.org/0000-0003-4142-1592)
- Navneet Singh (ORCID: https://orcid.org/0000-0002-8389-0701)
- Amanjit Bal (ORCID: https://orcid.org/0000-0002-1457-8589)
- Bhagwant Rai Mittal (ORCID: https://orcid.org/0000-0002-0016-5783)
- Harmandeep Singh (ORCID: https://orcid.org/0000-0002-1472-104X)
- Komal Preet (ORCID: https://orcid.org/0009-0007-4819-5547)
- Piyush Aggarwal (ORCID: https://orcid.org/0000-0002-3067-3113)
- Rajender Kumar (ORCID: https://orcid.org/0000-0001-5098-5707)
- Priyavrat Purohit
- Jaya Shukla (ORCID: https://orcid.org/0000-0003-3355-4168)
Institutions
- Pulmonary Associates (US)
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1097/rlu.0000000000006186
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00